AMAG
AMAG Pharmaceuticals, Inc.
AMAG
AMAG
Delisted
AMAG was delisted on the 13th of November, 2020.
173 hedge funds and large institutions have $898M invested in AMAG Pharmaceuticals, Inc. in 2018 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 68 increasing their positions, 49 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
173
Holders Change
+3
Holders Change %
+1.76%
% of All Funds
3.97%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
20
Increased
68
Reduced
49
Closed
16
Calls
$5.66M
Puts
$7.63M
Net Calls
-$1.98M
Net Calls Change
+$7.32M
Top Buyers
| 1 |
JSP
Jackson Square Partners
Larkspur,
California
|
+$52.1M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$12.8M |
| 3 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$9.81M |
| 4 |
SEI Investments
Oaks,
Pennsylvania
|
+$9.33M |
| 5 |
OM
Opaleye Management
Boston,
Massachusetts
|
+$8.19M |
Top Sellers
| 1 |
BC
Broadfin Capital
New York
|
-$12.1M |
| 2 |
TAM
Tocqueville Asset Management
New York
|
-$4.88M |
| 3 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$3.19M |
| 4 |
JGC
J. Goldman & Co
New York
|
-$3.05M |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$2.59M |
